The Chondroprotective Agent ITZ-1 Inhibits Interleukin-1β–Induced Matrix Metalloproteinase–13 Production and Suppresses Nitric Oxide–Induced Chondrocyte DeathHaruhide Kimura(Kanazawa University), Masayuki Takizawa(Takeda (Japan))Journal of Pharmacological SciencesJanuary 1, 200910.1254/jphs.09076fpCited by 22SaveCiteExport RISWatch citationsRelated PapersT‐495, a novel low cooperative M<sub>1</sub> receptor positive allosteric modulator, improves memory deficits associated with cholinergic dysfunction and is characterized by low gastrointestinal side effect risk|Pharmacology Research & Perspectives|2020|14